F2-isoprostanes are not just markers of oxidative stress

Free Radical Biology and Medicine

Volumn 44, Issue 3, 2008, Pages 247-256

  Comporti, Mario ^a   Signorini, Cinzia ^a   Arezzini, Beatrice ^a   Vecchio, Daniela ^a   Monaco, Barbara ^a   Gardi, Concetta ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Collagen synthesis; Free radicals; Hepatic stellate cells; Human promonocytic U937 cells; Isoprostanes; Oxidative stress; TGF ; Vasoactivity

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; 7 [3 [3 HYDROXY 4 (4 IODOPHENOXY) 1 BUTENYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL]HEPTENOIC ACID; ALDEHYDE DERIVATIVE; ALPHA SMOOTH MUSCLE ACTIN; BIOLOGICAL MARKER; CARBON TETRACHLORIDE; COLLAGEN; CYCLOPENTENONE DERIVATIVE; DOCOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID; ISOPROSTANE DERIVATIVE; THROMBOXANE A2 RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG; PROSTAGLANDIN F2ALPHA RECEPTOR; PROSTAGLANDIN RECEPTOR;

ADULT RESPIRATORY DISTRESS SYNDROME; ALCOHOL LIVER DISEASE; ALLERGIC ASTHMA; ALZHEIMER DISEASE; ARTERIOLE; ATHEROGENESIS; BRAIN MICROCIRCULATION; CELL PROLIFERATION; CHOLESTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLLAGEN SYNTHESIS; DIABETES MELLITUS; DNA SYNTHESIS; EXPERIMENTAL MODEL; GLOMERULUS; HEPATORENAL SYNDROME; HUMAN; HUNTINGTON CHOREA; HYPERHOMOCYSTEINEMIA; ISCHEMIA; KIDNEY ARTERY; KIDNEY FAILURE; LIPID PEROXIDATION; LIVER CELL CULTURE; LIVER FIBROSIS; METHODOLOGY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; RETINA BLOOD VESSEL; RETROLENTAL FIBROPLASIA; REVIEW; SIGNAL TRANSDUCTION; SMOKING; STELLATE CELL; ANIMAL; CHEMISTRY; DRUG EFFECT; LIVER; LIVER CIRRHOSIS; LUNG FIBROSIS; METABOLISM; PATHOLOGY; RAT;

RATTUS;

ANIMALS; BIOLOGICAL MARKERS; COLLAGEN; F2-ISOPROSTANES; HUMANS; LIPID PEROXIDATION; LIVER; LIVER CIRRHOSIS; OXIDATIVE STRESS; PULMONARY FIBROSIS; RATS; RECEPTORS, PROSTAGLANDIN;

EID: 38149020624     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.10.004     Document Type: Review

References (104)

1. Hochstein P., and Ernster L. ADP-activated lipid peroxidation coupled to the TPNH oxidase system of microsomes. Biochemistry 2 (1963) 1420-1428
2. Slater T.F. Free radical mechanisms in tissue injury (1972), Pion, London
3. Comporti M., Saccocci C., and Dianzani M.U. Effect of CCl4 in vitro and in vivo on lipid peroxidation of rat liver homogenates and subcellular fractions. Enzymologia 29 (1965) 185-204
4. McCord J.M., and Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244 (1969) 6049-6055
5. Sies H. Oxidative stress (1985), Academic Press, London
6. Poyer J.L., Floyd R.A., McCay P.B., Janze E.G., and Davis E.R. Spin-trapping of the trichloromethyl radical produced during enzymic NADPH oxidation in the presence of carbon tetrachloride or bromotrichloromethane. Biochim. Biophys. Acta 539 (1978) 402-409
7. Albano E., Lott K.A., Slater T.F., Stier A., Symons M.C., and Tomasi A. Spin-trapping studies on the free-radical products formed by metabolic activation of carbon tetrachloride in rat liver microsomal fractions isolated hepatocytes and in vivo in the rat. Biochem. J. 204 (1982) 593-603
8. 4 activation using pulse radiolysis and high energy radiation procedures. FEBS Lett. 122 (1980) 303-306
9. Benedetti A., Casini A.F., Ferrali M., and Comporti M. Extraction and partial characterization of dialysable products originating from the peroxidation of liver microsomal lipids and inhibiting microsomal glucose 6-phosphatase activity. Biochem. Pharmacol. 28 (1979) 2909-2918
10. Benedetti A., Comporti M., and Esterbauer H. Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim. Biophys. Acta 620 (1980) 281-296
11. Esterbauer H., Schaur R.J., and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11 (1991) 81-128
12. Benedetti A., Pompella A., Fulceri R., Romani A., and Comporti M. Detection of 4-hydroxynonenal and other lipid peroxidation products in the liver of bromobenzene-poisoned mice. Biochim. Biophys. Acta 876 (1986) 658-666
13. Comporti M. Three models of free radical-induced cell injury. Chem. Biol. Interact. 72 (1989) 1-56
14. Comporti M. Glutathione depleting agents and lipid peroxidation. Chem. Phys. Lipids 45 (1987) 143-169
15. Gage J.C. The action of paraquat and diquat on the respiration of liver cell fractions. Biochem. J. 109 (1968) 757-761
16. Farrington J.A., Ebert M., Land E.J., and Fletcher K. Bipyridylium quaternary salts and related compounds. V. Pulse radiolysis studies of the reaction of paraquat radical with oxygen: implications for the mode of action of bipyridyl herbicides. Biochim. Biophys. Acta 314 (1973) 372-381
17. Bus J.S., Aust S.D., and Gibson J.E. Superoxide- and singlet oxygen-catalyzed lipid peroxidation as a possible mechanism for paraquat (methyl viologen) toxicity. Biochem. Biophys. Res. Commun. 58 (1974) 749-755
18. Bachur N.R., Gordon S.L., and Gee M.V. Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation. Mol. Pharmacol. 13 (1977) 901-910
19. Kalyanaraman B., Perez-Reyes E., and Mason R.P. Spin-trapping and direct electron spin resonance investigations of the redox metabolism of quinone anticancer drugs. Biochim. Biophys. Acta 630 (1980) 119-130
20. Bellomo G., and Orrenius S. Altered thiol and calcium homeostasis in oxidative hepatocellular injury. Hepatology 5 (1985) 876-882
21. Bellomo G., Jewell S.A., Thor H., and Orrenius S. Regulation of intracellular calcium compartmentation: studies with isolated hepatocytes and t-butyl hydroperoxide. Proc. Natl. Acad. Sci. USA 79 (1982) 6842-6846
22. Bellomo G., Jewell S.A., and Orrenius S. The metabolism of menadione impairs the ability of rat liver mitochondria to take up and retain calcium. J. Biol. Chem. 257 (1982) 11558-11562
23. Morrow J.D., Harris T.M., and Roberts L.J. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal. Biochem. 184 (1990) 1-10
24. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. USA 87 (1990) 9383-9387
25. 2-isoprostanes) are formed in situ on phospholipids. Proc. Natl. Acad. Sci. USA 89 (1992) 10721-10725
26. Morrow J.D., and Roberts L.J. The isoprostanes: current knowledge and directions for future research. Biochem. Pharmacol. 51 (1996) 1-9
27. 4 poisoning?. Free Radic. Biol. Med. 38 (2005) 698-710
28. Nanji A.A., Khwaja S., Tahan S.R., and Sadrzadeh S.M. Plasma levels of a novel noncyclooxygenase-derived prostanoid (8-isoprostane) correlate with severity of liver injury in experimental alcoholic liver disease. J. Pharmacol. Exp. Ther. 269 (1994) 1280-1285
29. 2-isoprostane excretion in alcoholic liver disease. Free Radic. Biol. Med. 26 (1999) 656-660
30. 2-isoprostanes) in the hepatorenal syndrome. J. Lipid Mediat. 6 (1993) 417-420
31. 2 receptor. Kidney Int. 55 (1999) 271-277
32. 2-isoprostane and 4-hydroxynonenal excretion in human bile of patients with biliary tract and pancreatic disorders. Am. J. Gastroenterol. 92 (1997) 2069-2072
33. 2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Circulation 96 (1997) 3314-3320
34. Mathews W.R., Guido D.M., Fisher M.A., and Jaeschke H. Lipid peroxidation as molecular mechanism of liver cell injury during reperfusion after ischemia. Free Radic. Biol. Med. 16 (1994) 763-770
35. Möbert J., and Becker B.F. Cyclooxygenase inhibition aggravates ischemia-reperfusion injury in the perfused guinea pig heart: involvement of isoprostanes. J. Am. Coll. Cardiol. 31 (1998) 1687-1694
36. Delanty N., Reilly M.P., Pratico D., Lawson J.A., McCarthy J.F., Wood A.E., Ohnishi S.T., Fitzgerald D.J., and FitzGerald G.A. 8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. Circulation 95 (1997) 2492-2499
37. 2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 99 (1999) 224-229
38. 2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett. 368 (1995) 225-229
39. 2alpha-III, an index of oxidant stress. Am. J. Respir. Crit. Care Med. 158 (1998) 1709-1714
40. Dworski R., Murray J.J., Roberts L.J., Oates J.A., Morrow J.D., Fisher L., and Sheller J.R. Allergen-induced synthesis of F(2)-isoprostanes in atopic asthmatics: evidence for oxidant stress. Am. J. Respir. Crit. Care Med. 160 (1999) 1947-1951
41. Carpenter C.T., Price P.V., and Christman B.W. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest 114 (1998) 1653-1659
42. 2-isoprostane levels are increased in Alzheimer's disease. Ann. Neurol. 44 (1998) 410-413
43. 2-isoprostane concentration in probable AD. Neurology 52 (1999) 562-565
44. 2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. FASEB J. 12 (1998) 1777-1783
45. 2-isoprostanes are elevated in Huntington's disease. Neurology 52 (1999) 1104-1105
46. 2 alpha on retinal vessels. Am. J. Physiol. 274 (1998) R1406-R1416
47. Hardy P., Dumont I., Bhattacharya M., Hou X., Lachapelle P., Varma D.R., and Chemtob S. Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy. Cardiovasc. Res. 47 (2000) 489-509
48. 2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N. Engl. J. Med. 332 (1995) 1198-1203
49. Reilly M., Delanty N., Lawson J.A., and FitzGerald G.A. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94 (1996) 19-25
50. Roberts L.J., and Morrow J.D. Isoprostanes as markers of lipid peroxidation in atherosclerosis. In: Serhan C.N., and Ward P.A. (Eds). Molecular biology of inflammation (1999), Humana Press, Totowa, NJ 141-163
51. Gniwotta C., Morrow J.D., Roberts II L.J., and Kühn H. Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 3236-3241
52. Reilly M.P., Praticò D., Delanty N., DiMinno G., Tremoli E., Rader D., Kapoor S., Rokach J., Lawson J., and FitzGerald G.A. Increased formation of distinct F2 isoprostanes in hypercholesterolemia. Circulation 98 (1998) 2822-2828
53. Moore K.P., Holt S.G., Patel R.P., Svistunenko D.A., Zackert W., Goodier D., Reeder B.J., Clozel M., Anand R., Cooper C.E., Morrow J.D., Wilson M.T., Darley-Usmar V., and Roberts II L.J. A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J. Biol. Chem. 273 (1998) 31731-31737
54. Holt S., Reeder B., Wilson M., Harvey S., Morrow J.D., Roberts II L.J., and Moore K. Increased lipid peroxidation in patients with rhabdomyolysis. Lancet 353 (1999) 1241
55. Voutilainen S., Morrow J.D., Roberts II L.J., Alfthan G., Alho H., Nyyssönen K., and Salonen J.T. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 1263-1266
56. 2-isoprostanes) in carbon tetrachloride hepatotoxicity: an animal model of lipid peroxidation. J. Clin. Invest. 90 (1992) 2502-2507
57. Yang Z.P., Morrow J., Wu A., Roberts L.J., and Dettbarn W.D. Diisopropylphosphorofluoridate-induced muscle hyperactivity associated with enhanced lipid peroxidation in vivo. Biochem. Pharmacol. 52 (1996) 357-361
58. 2-isoprostanes. Anesthesiology 84 (1996) 910-916
59. 2-isoprostanes in vivo by acute Cr(VI) poisoning. Chem. Res. Toxicol. 11 (1998) 1516-1520
60. 2-isoprostanes as markers of in vivo lipid peroxidation-a comparison of enzyme immunoassay with gas chromatography/mass spectrometry. Anal. Biochem. 272 (1999) 209-215
61. 2alpha type III in human urine by gas chromatography-electronic impact mass spectrometry: comparison with enzyme immunoassay. J. Chromatogr. B Biomed. Sci. Appl. 754 (2001) 333-343
62. 2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure. J. Chromatogr. B Biomed. Appl. 667 (1995) 199-208
63. 2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism. In: Packer L. (Ed). Methods in enzymology. Oxygen radicals in biological systems, part C vol. 233 (1994), Academic Press, San Diego 163-179
64. 2-isoprostanes. J. Mass. Spectrom. 38 (2003) 1067-1074
65. Comporti M., Hartman A., and Di Luzio N.R. Effect of in vivo and in vitro ethanol administration on liver lipid peroxidation. Lab. Invest. 16 (1967) 616-624
66. Ivester P., Roberts II L.J., Young T., Stafforini D., Vivian J., Lees C., Young J., Daunais J., Friedman D., Rippe R.A., Parsons C.J., Grant K.A., and Cunningham C. Ethanol self-administration and alterations in the livers of the cynomolgus monkey, Macaca fascicularis. Alcohol. Clin. Exp. Res. 31 (2007) 144-155
67. 2 receptors. J. Clin. Invest. 90 (1992) 136-141
68. 2-isoprostane receptors on rat vascular smooth muscle cells. Am. J. Physiol. 264 (1993) C1619-C1624
69. 2. Am. J. Physiol. 272 (1997) F477-F483
70. 2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells. Kidney Int. 56 (1999) 471-478
71. Reynaud X., and Dorey C.K. Extraretinal neovascularization induced by hypoxic episodes in the neonatal rat. Invest. Ophthalmol. Visual Sci. 35 (1994) 3169-3177
72. Phelps D.L., and Rosenbaum A.L. Effects of marginal hypoxemia on recovery from oxygen-induced retinopathy in the kitten model. Pediatrics 73 (1984) 1-6
73. Montero A., Munger K.A., Khan R.Z., Valdivielso J.M., Morrow J.D., Guasch A., Ziyadeh F.N., and Badr K.F. F(2)-isoprostanes mediate high glucose-induced TGF-beta synthesis and glomerular proteinuria in experimental type I diabetes. Kidney Int. 58 (2000) 1963-1972
74. Taber D.F., Morrow J.D., and Roberts II L.J. A nomenclature system for the isoprostanes. Prostaglandins 53 (1997) 63-67
75. Morrow J.D., Minton T.A., Mukundan C.R., Campbell M.D., Zackert W.E., Daniel V.C., Badr K.F., Blair I.A., and Roberts II L.J. Free radical-induced generation of isoprostanes in vivo: evidence for the formation of D-ring and E-ring isoprostanes. J. Biol. Chem. 269 (1994) 4317-4326
76. Morrow J.D., Awad J.A., Wu A., Zackert W.E., Daniel V.C., and Roberts II L.J. Nonenzymatic free radical-catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo. J. Biol. Chem. 271 (1996) 23185-23190
77. Hou X., Roberts II L.J., Gobeil Jr. F., Taber D., Kanai K., Abran D., Brault S., Checchin D., Sennlaub F., Lachapelle P., Varma D., and Chemtob S. Isomer-specific contractile effects of a series of synthetic F2-isoprostanes on retinal and cerebral microvasculature. Free Radic. Biol. Med. 36 (2004) 163-172
78. Roberts II L.J., and Morrow J.D. Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation. Cell. Mol. Life Sci. 59 (2002) 808-820
79. Chen Y., Morrow J.D., and Roberts II L.J. Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway. J. Biol. Chem. 274 (1999) 10863-10868
80. Boyland E., and Chasseaud L.F. Enzymes catalysing conjugations of glutathione with alpha-beta-unsaturated carbonyl compounds. Biochem. J. 109 (1968) 651-661
81. Atsmon J., Sweetman B.J., Baertschi S.W., Harris T.M., and Roberts II L.J. Formation of thiol conjugates of 9-deoxy-delta 9,delta 12(E)-prostaglandin D2 and delta 12(E)-prostaglandin D2. Biochemistry 29 (1990) 3760-3765
82. Brame C.J., Salomon R.G., Morrow J.D., and Roberts II L.J. Identification of extremely reactive gamma-ketoaldehydes (isolevuglandins) as products of the isoprostane pathway and characterization of their lysyl protein adducts. J. Biol. Chem. 274 (1999) 13139-13146
83. Salomon R.G., Miller D.B., Zagorski M.G., and Coughlin D.J. Prostaglandin endoperoxides. 14. Solvent-induced fragmentation of prostaglandin endoperoxides: new aldehyde products from PGH2 and a novel intramolecular 1,2-hydride shift during endoperoxide fragmentation in aqueous solution. J. Am. Chem. Soc. 106 (1984) 6049-6060
84. Nourooz-Zadeh J., Halliwell B., and Anggård E.E. Evidence for the formation of F3-isoprostanes during peroxidation of eicosapentaenoic acid. Biochem. Biophys. Res. Commun. 236 (1997) 467-472
85. Salem Jr. N., Kim H.Y., and Yergey J.A. Docosahexaenoic acid: membrane function and metabolism. In: Simopoulos A.P., Kifer R.R., and Martin R.E. (Eds). Health effects of polyunsaturated fatty acids in seafoods (1986), Academic Press, Orlando 263-317
86. Skinner E.R., Watt C., Besson J.A., and Best P.V. Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects. Brain 116 (1993) 717-725
87. Roberts II L.J., Montine T.J., Markesbery W.R., Tapper A.R., Hardy P., Chemtob S., Dettbarn W.D., and Morrow J.D. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem. 273 (1998) 13605-13612
88. Montine T.J., Markesbery W.R., Morrow J.D., and Roberts II L.J. Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease. Ann. Neurol. 44 (1998) 410-413
89. Chojkier M., Houglum K., Solis-Herruzo J., and Brenner D.A. Stimulation of collagen gene expression by ascorbic acid in cultured human fibroblasts: a role for lipid peroxidation?. J. Biol. Chem. 264 (1989) 16957-16962
90. Parola M., Pinzani M., Casini A., Albano E., Poli G., Gentilini A., Gentilini P., and Dianzani M.U. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen α1 (I) gene expression in human liver fat-storing cells. Biochem. Biophys. Res. Commun. 194 (1993) 1044-1050
91. Leonarduzzi G., Scavazza A., Biasi F., Chiarpotto E., Camandola S., Vogel S., Dargel R., and Poli G. The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J. 11 (1997) 851-857
92. Zamara E., Novo E., Marra F., Gentilini A., Romanelli R.G., Caligiuri A., Robino G., Tamagno E., Aragno M., Danni O., Autelli R., Colombatto S., Dianzani M.U., Pinzani M., and Parola M. 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. J. Hepatol. 40 (2004) 60-68
93. 2-isoprostanes are elevated in newborns and inversely correlated to gestational age. Free Radic. Biol. Med. 37 (2004) 724-732
94. 2-isoprostanes stimulate collagen synthesis in activated hepatic stellate cells: a link with liver fibrosis?. Lab. Invest. 85 (2005) 1381-1391
95. Zhang K., Rekhter M.D., Gordon D., and Phan S.H. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis: a combined immunohistochemical and in situ hybridization study. Am. J. Pathol. 145 (1994) 114-125
96. Zhang K., Flanders K.C., and Phan S.H. Cellular localization of transforming growth factor-beta expression in bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 147 (1995) 352-361
97. Darby I., Skalli O., and Gabbiani G. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab. Invest. 63 (1990) 21-29
98. Welch M.P., Odland G.F., and Clark R.A. Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J. Cell Biol. 110 (1990) 133-145
99. Singer I.I., Kawka D.W., Kazazis D.M., and Clark R.A. In vivo co-distribution of fibronectin and actin fibers in granulation tissue: immunofluorescence and electron microscope studies of the fibronexus at the myofibroblast surface. J. Cell Biol. 98 (1984) 2091-2106
100. Kuhn C., and McDonald J.A. The roles of the myofibroblast in idiopathic pulmonary fibrosis: ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am. J. Pathol. 138 (1991) 1257-1265
101. Mitchell J., Woodcock-Mitchell J., Reynolds S., Low R., Leslie K., Adler K., Gabbiani G., and Skalli O. Alpha-smooth muscle actin in parenchymal cells of bleomycin-injured rat lung. Lab. Invest. 60 (1989) 643-650
102. Trush M.A., Mimnaugh E.G., Ginsburg E., and Gram T.E. Studies on the interaction of bleomycin A2 with rat lung microsomes. I. Characterization of factors which influence bleomycin-mediated DNA chain breakage. J. Pharmacol. Exp. Ther. 221 (1982) 152-158
103. Kang K.H., Morrow J.D., Roberts L.J., Newman J.H., and Banerjee M. Airway and vascular effects of 8-epi-prostaglandin F2 alpha in isolated perfused rat lung. J. Appl. Physiol. 74 (1993) 460-465
104. Diegelmann R.F., and Peterkofsky B. Inhibition of collagen secretion from bone and cultured fibroblasts by microtubular disruptive drugs. Proc. Natl. Acad. Sci. U.S.A. 69 (1972) 892-896